Background: Donor-derived human parvovirus B19 infections are rarely reported. Thus, it's
incidence in kidney transplantation is still unknown due to lack of surveillance studies …

Background Parvovirus B19 presents tropism for human erythroid progenitor cells, causing
chronic anemia in organ transplant recipients, due to their suppressed humoral and cellular …

Background Parvovirus B19 is a small, non‐enveloped, single‐stranded DNA virus with a
special affinity for the erythroid progenitor cells of the bone marrow. The first case of …

Kidney transplant (KT) recipients can develop symptomatic Parvovirus (PV) B19 infections,
frequently associated with persistent anemia. The aim of this study was to evaluate the …

Background There is a lack of epidemiological studies on the course and clinical
characteristics of Parvovirus B19 (B19V) infections in kidney transplant (KT) recipients. This …

Described for the first time in 1986, Parvovirus B19 (B19V) infection in kidney transplant
recipients remains little‐known and probably underestimated. The aims of this study were to …

BACKGROUND: Extremely high viremic levels of parvovirus B19 (B19V) can be found in
acutely infected, but asymptomatic donors. However, reports of transmission by single …

Human parvovirus B19 (B19) infection has been known to cause chronic anemia, pure red
cell aplasia (PRCA), glomerulopathy, and allograft dysfunction in kidney transplant (KT) …

Abstract Background and Objectives: Blood donor units are not screened for human
parvovirus B19 (B19) even though it can be acquired via blood products. We estimated the …

Background After acute parvovirus B19 (B19V) infection of immunocompetent individuals,
viral genomes persist lifelong in various tissues. In immunocompromized patients, acute …